Citius Oncology
CTOR
11 hedge funds and large institutions have $230K invested in Citius Oncology in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
304% more capital invested
Capital invested by funds: $57K → $230K (+$173K)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
57% more funds holding
Funds holding: 7 → 11 (+4)
0.22% more ownership
Funds ownership: 0.06% → 0.28% (+0.22%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$77K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$26K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$25.5K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$23.7K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
+$15.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$14K |
| 2 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$3.93K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HF
1
HRT Financial
New York
| $78K | +$77K | +68,543 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $28.5K | +$26K | +23,173 | +1,420% |
|
|
3
Citadel Advisors
Miami,
Florida
| $26.1K | +$25.5K | +22,699 | New |
|
|
IA
4
IFP Advisors
Tampa,
Florida
| $25.5K | +$15.8K | +14,080 | +173% |
|
|
XT
5
XTX Topco
George Town,
Cayman Islands
| $24.3K | +$23.7K | +21,095 | New |
|
6
Geode Capital Management
Boston,
Massachusetts
| $14.5K | +$14.2K | +12,651 | New |
|
|
YCM
7
Yakira Capital Management
Westport,
Connecticut
| $13.8K | -$3.93K | -3,500 | -23% |
|
8
Renaissance Technologies
New York
| $12.9K | +$12.6K | +11,196 | New |
|
9
Osaic Holdings
Scottsdale,
Arizona
| $6.3K | – | – | – |
|
10
Bank of America
Charlotte,
North Carolina
| $184 | – | – | – |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $47 | – | – | – |
|
|
VF
12
Virtu Financial
New York
| – | -$14K | -10,291 | Closed |
|
CTOR Hedge Fund Activity: Q4 2024 in Review
11 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Citius Oncology (CTOR) for Q4 2024, worth a combined $230K — up 304% from $57K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CTOR positions and 1 closed out — a net gain of 4 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $77K. The largest seller was Virtu Financial, exiting entirely with an estimated $14K sold.
- 11 institutional investors held Citius Oncology (CTOR) as of Q4 2024, up from 7 in Q3 2024.
- Funds reported $230K of Citius Oncology stock for Q4 2024, up 304% quarter-over-quarter.
- 5 funds opened new Citius Oncology positions in Q4 2024 and 1 closed out, a net change of +4 holders.
- The largest Citius Oncology buyer in Q4 2024 was HRT Financial, an estimated $77K added.
- The largest Citius Oncology seller in Q4 2024 was Virtu Financial, an estimated $14K sold.
Based on aggregated 13F filings for Q4 2024.